IBD Drive Time: Upadacitinib Therapy for Crohn’s Disease

The podcast discusses the effectiveness of Upadacitinib therapy for Crohn's disease, highlighting its superior alternative to placebo. They review the trial results, efficacy, tolerability, and safety of the drug. The speakers also discuss treatment approaches for active IBD and spondyloarthropathy, as well as the potential benefits of jack inhibitors for pydderma. They touch on clinical trial results, dosing considerations, and conclude that the benefits of Upadacitinib outweigh the risks.